MARKET

ALT

ALT

Altimmune
NASDAQ
3.380
+0.050
+1.50%
After Hours: 3.420 +0.04 +1.18% 19:40 04/07 EDT
OPEN
3.340
PREV CLOSE
3.330
HIGH
3.450
LOW
3.255
VOLUME
2.04M
TURNOVER
--
52 WEEK HIGH
7.73
52 WEEK LOW
2.870
MARKET CAP
439.76M
P/E (TTM)
-3.3803
1D
5D
1M
3M
1Y
5Y
1D
Altimmune Insider Makes Bold New Share Grab
TipRanks · 1d ago
Altimmune director John Gill buys 9,200 shares worth $31,348
Reuters · 1d ago
Weekly Report: what happened at ALT last week (0330-0403)?
Weekly Report · 1d ago
Gitlab, Altimmune, Cheniere, Pacific Biosciences, Hercules Shock Wall Street
TipRanks · 3d ago
Top Altimmune Insiders Quietly Boost Their Stakes in a Big Way
TipRanks · 6d ago
Altimmune CFO Gregory Weaver acquires $31,499 common shares
Reuters · 6d ago
Altimmune CEO Jerome Durso acquires $0.0 million common shares
Reuters · 6d ago
BUZZ-Eli Lilly rises after US FDA approves weight-loss pill
Reuters · 6d ago
More
About ALT
Altimmune, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing next-generation peptide-based therapeutics. It is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity, metabolic dysfunction-associated steatohepatitis (MASH) and other indications. Activation of the GLP-1 and glucagon receptors is believed to mimic the complementary effects of diet and exercise on weight loss, with GLP-1 suppressing appetite and glucagon increasing energy expenditure. Glucagon is also recognized as having direct effects on hepatic fat metabolism, to rapid reductions in levels of liver fat and serum lipids. The Company has completed the MOMENTUM Phase II obesity trial and is being studied in the IMPACT Phase IIb MASH trial. The Company also develops and commercializes surfactant-functionalized (EuPort domain) incretin-based peptide therapeutics, including (GLP-1-glucagon)/oxyntomodulin, and variants.

Webull offers Altimmune Inc stock information, including NASDAQ: ALT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALT stock methods without spending real money on the virtual paper trading platform.